New drugs on the horizon for pancreatic cancer
New drugs on the horizon for pancreatic cancer
Neo-adjuvant/adjuvant treatment in gastric cancer
Recommendations for surveillance of adenomas
New evolutions for the neoadjuvant and adjuvant treatment of oesophageal cancer
Do variations in prognostic risk stratification criteria for patients with gastrointestinal stromal tumours affect adjuvant treatment?
Implementation of a wait and see program for rectal cancer
Cholangiocarcinoma and gallbladder cancer
Left versus right in colon cancer
The GI oncologist of the future
Minimally invasive surgery for cancer of the oesophagus
Acquired resistance to EGFR antibodies